- Report
- August 2025
- 50 Pages
Global
From €2353EUR$2,650USD£2,041GBP
Fidarestat is a gastrointestinal drug used to treat symptoms of gastroesophageal reflux disease (GERD). It is a proton pump inhibitor (PPI) that works by reducing the amount of acid produced in the stomach. Fidarestat is available in both prescription and over-the-counter forms. It is used to treat symptoms such as heartburn, regurgitation, and chest pain. It is also used to prevent ulcers and to treat conditions such as erosive esophagitis and Zollinger-Ellison syndrome.
Fidarestat is a widely used drug in the gastrointestinal market. It is one of the most commonly prescribed PPIs and is available in many countries around the world. It is often used as a first-line treatment for GERD and is generally well-tolerated.
Some companies in the Fidarestat market include AstraZeneca, Takeda Pharmaceuticals, and Pfizer. Show Less Read more